INNPF

Consumer Defensive Household & Personal Products

InnoCan Pharma Corporation

$1.40

-0.00 -0.00% today

Price History

Not enough data

Key Stats

Market Cap

6.30M

Avg Volume

EPS

-$0.26

52W High

$14.26

52W Low

$1.40

Div. Yield

0.0%

Valuation

P/B Ratio

1.31

P/S Ratio

0.27

EV/EBITDA

-1.23

EV/Revenue

0.18

Margins

Gross Margin 90.5%

Operating Margin (9.7%)

Net Margin (4.1%)

EBITDA Margin (14.4%)

Growth & Returns

Revenue Growth (YoY)

(25.1%)

Return on Equity

(11.8%)

Return on Assets

(20.1%)

Liquidity & Leverage

Current Ratio

5.25

Quick Ratio

3.78

Debt / Equity

0.22

Total Cash

6.40M

Total Debt

1.66M

About

InnoCan Pharma Corporation operates as a pharmaceutical technology company in United States, Canada, Europe, and internationally. The company operates through two segments, Online sales and Other Operations. The company develops a cannabidiol (CBD)-loaded liposome drug delivery platform (CBD-LPT), which is in the preclinical trial phase to treat chronic pain management for human and veterinary health sectors. It also offers a pain-relieving topical composition, as well as compositions for the treatment of hemorrhoid, psoriasis of the scalp, vaginal atrophy, and diabetic symptoms. The company is also involved in development, manufacture, and marketing of cosmetic products. InnoCan Pharma Corporation was founded in 2017 and is headquartered in Calgary, Canada.

innocanpharma.com